BioSpace News Archive

As per Precedence Research, The healthcare information systems market size is expected to surpass around US$ 487.8 billion by 2030 and expanding growth at a CAGR of 7.8% from 2022 to 2030.

The pharmaceutical logistics market is projected to garner grow at a CAGR of 8.3% during the forecast period and expected to reach over US$ 159.14 billion by 2030.

Moderna, Inc. announced that it has received approval from the US FDA for its amendment to the emergency use authorization to allow for a second booster dose of its COVID-19 vaccine at the 50 µg dose level in adults 50 years of age and older who have received an initial booster of any of the authorized or approved COVID-19 vaccines and adults 18 years of age and older with certain kinds of immunocompromise.

Seno Medical’s Imagio® Breast Imaging System has been named a finalist in the 2022 Medical Device Excellence Awards, in the Radiological, Imaging, and Electromechanical Devices category.

Over three days, the patients will receive three intravenous doses of the drug and their clinical progress, as well as the development of the inflammatory process.

ABIONYX Pharma (FR0012616852 – ABNX – PEA PME eligible) (Paris:ABNX), a new generation biotech company dedicated to the discovery and development of innovative therapies for patients, today announced that the U.S. Food and Drug Administration (FDA) has granted orphan-drug designation (ODD) to the Bio-HDL CER-001 for the treatment of lecithin-cholesterol acyltransferase (LCAT) deficiency.

Alphamab Oncology reported financial results for the full year ended December 31, 2021 and highlighted recent progress and upcoming milestones.

ViiV Healthcare, the global specialist HIV company majority owned by GlaxoSmithKline plc (“GSK”), with Pfizer Inc. and Shionogi B.V. as shareholders, today announced that the US Food and Drug Administration (FDA) has approved Cabenuva.

Life science researchers can explore new ideas for genome engineering technology through a newly announced post-doctoral research program launched by Promega with mentoring support from AstraZeneca.

According to Report, the global connected health and wellness solutions market size is predicted to rake around USD 186.10 billion by 2030 and registering a CAGR of 20.0% from 2022 to 2030.